journal article·2024-11

Golgi apparatus-targeted BODIPY-based photosensitizer synergized with glutaminase inhibition for enhanced photodynamic therapy

Jiawei Li, Qiqi Yu, Yang Li, Dongdong Xu, Shouchun Yin

Dyes and Pigments· Volume 230
Publisher page

Abstract

No abstract is available for this record. The assistant can identify its topic from the title, but cannot infer the study’s results.

Source: Not provided · Quality: missing

Research context

OpenAlex topics: Nanoplatforms for cancer theranostics · Photodynamic Therapy Research Studies · Luminescence and Fluorescent Materials

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (59)

Show source-provided references
1. Radiomics and artificial intelligence for precision medicine in lung cancer treatment10.1016/j.semcancer.2023.05.004 ↗
2. Radiotherapy combined with immunotherapy: the dawn of cancer treatment10.1038/s41392-022-01102-y ↗
3. Understanding and overcoming tumor heterogeneity in metastatic breast cancer treatment10.1038/s43018-021-00229-1 ↗
4. Photodynamic treatment of acute vascular occlusion by using an iron-nitrosyl complex10.1016/j.chempr.2023.02.013 ↗
5. Adipocyte-targeting type I AIE photosensitizer for obesity treatment via photodynamic lipid peroxidation10.1021/acsnano.3c03654 ↗
6. Redox regulation and its emerging roles in cancer treatment10.1016/j.ccr.2022.214897 ↗
7. Photosensitizers with aggregation-induced emission: Materials and biomedical applications10.1002/adma.201801350 ↗
8. Cancer-cell-activated in situ synthesis of mitochondria-targeting AIE photosensitizer for precise photodynamic therapy10.1002/anie.202017350 ↗
9. Mitochondria targeted fluorogenic theranostic agents for cancer therapy10.1016/j.ccr.2021.214283 ↗
10. Mitochondria-specific agents for photodynamic cancer therapy: a key determinant to boost the efficacy10.1002/adhm.202001240 ↗
11. Mitochondrial DNA stress signalling protects the nuclear genome10.1038/s42255-019-0150-8 ↗
12. Dopamine oxidation mediates mitochondrial and lysosomal dysfunction in Parkinson's disease10.1126/science.aam9080 ↗
13. Lysosomal–mitochondrial cross-talk during cell death10.1016/j.mito.2010.07.008 ↗
14. Mitochondria–lysosome contacts regulate mitochondrial fission via RAB7 GTP hydrolysis10.1038/nature25486 ↗
15. Mitochondria-associated endoplasmic reticulum membrane: Overview and inextricable link with cancer10.1111/jcmm.17696 ↗
16. Potential role of mitochondria-associated endoplasmic reticulum membrane proteins in diseases10.1016/j.bcp.2022.115011 ↗
17. New insights into the role of mitochondria-associated endoplasmic reticulum membrane10.1016/B978-0-12-386033-0.00002-5 ↗
18. Membrane traffic within the Golgi apparatus10.1146/annurev.cellbio.24.110707.175421 ↗
19. Targeting of proteins to the Golgi apparatus10.1007/s004180050252 ↗
20. Biosynthetic protein transport and sorting by the endoplasmic reticulum and Golgi10.1146/annurev.bi.56.070187.004145 ↗
21. Golgi apparatus-targeted aggregation-induced emission luminogens for effective cancer photodynamic therapy10.1038/s41467-022-29872-7 ↗
22. Ratiometric fluorescence imaging of Golgi H2O2 reveals a correlation between Golgi oxidative stress and hypertension10.1039/C9SC04384E ↗
23. An off–on COX-2-specific fluorescent probe: targeting the Golgi apparatus of cancer cells10.1021/ja4056905 ↗
24. A nile blue based infrared fluorescent probe: imaging tumors that over-express cyclooxygenase-210.1039/C4CC08915D ↗
25. Enzymatic assemblies of thiophosphopeptides instantly target Golgi apparatus and selectively kill cancer cells10.1002/anie.202102601 ↗
26. Rational design of a targetable fluorescent probe for visualizing H2S production under Golgi stress response elicited by monensin10.1021/acs.analchem.9b04009 ↗
27. An integrated fluorescent probe for ratiometric detection of glutathione in the Golgi apparatus and activated organelle-targeted therapy10.1021/acs.analchem.1c03836 ↗
28. Golgi-targetable fluorescent probe for ratiometric imaging of CO in cells and zebrafish10.1016/j.snb.2021.130631 ↗
29. Enzyme-responsive peptide thioesters for targeting Golgi apparatus10.1021/jacs.2c02238 ↗
30. A Golgi-targeting and dual-color “turn-on” probe for spatially precise imaging of furin10.1021/acs.analchem.0c04186 ↗
31. A novel Golgi-targetable fluorescent probe for imaging peroxynitrite in Golgi stress and sepsis-induced acute lung injury10.1016/j.snb.2022.132352 ↗
32. A Golgi-targeted fluorescent probe for imaging H2O2 and releasing H2S during Golgi stress10.1016/j.dyepig.2023.111521 ↗
33. Recent advances in Golgi-targeted small-molecule fluorescent probes10.1016/j.ccr.2022.214504 ↗
34. Engineering nanomedicine for glutathione depletion-augmented cancer therapy10.1039/D0CS00718H ↗
35. Glutathione-mediated nanomedicines for cancer diagnosis and therapy10.1016/j.cej.2021.128880 ↗
36. Application of glutathione depletion in cancer therapy: enhanced ROS-based therapy, ferroptosis, and chemotherapy10.1016/j.biomaterials.2021.121110 ↗
37. Glutathione-depleting nanomedicines for synergistic cancer therapy10.1021/acsnano.1c00498 ↗
38. Near-infrared boron–dipyrrin (BODIPY) nanomaterials: molecular design and anti-tumor therapeutics10.1016/j.ccr.2024.215718 ↗
39. Rational design of amphiphilic BODIPY-based photosensitizers for multimodal imaging-guided phototherapy10.1039/D3QM00239J ↗
40. Phenylthiol-BODIPY-based supramolecular metallacycles for synergistic tumor chemo-photodynamic therapy10.1073/pnas.2203994119 ↗
41. Strategies to address key challenges of metallacycle/metallacage-based supramolecular coordination complexes in biomedical applications10.1039/D3CS00926B ↗
42. The tumor EPR effect for cancer drug delivery: current status, limitations, and alternatives10.1016/j.addr.2022.114614 ↗
43. Tumor metabolism-rewriting nanomedicines for cancer immunotherapy10.1021/acscentsci.3c00702 ↗
44. A comparative pharmaco-metabolomic study of glutaminase inhibitors in glioma stem-like cells confirms biological effectiveness but reveals differences in target-specificity10.1038/s41420-020-0258-3 ↗
45. Carrier-free immunotherapeutic nano-booster with dual synergistic effects based on glutaminase inhibition combined with photodynamic therapy10.1021/acsnano.2c11037 ↗
46. Di(acenaphtho)BODIPYs as deep red fluorescence probes for reactive oxygen species10.1016/j.dyepig.2024.112192 ↗
47. Regulating 1O2 generation from heavy-atom-free triplet photosensitizers based on thiophene-fused BODIPY10.1016/j.dyepig.2023.111617 ↗
48. tert-Butyl substituted aza-BODIPY-based bromides for phototherapy10.1016/j.dyepig.2024.112213 ↗
49. BODIPY as a multifunctional theranostic reagent in biomedicine: self-assembly, properties, and applications10.1002/adma.202207546 ↗
50. Partition coefficients and their uses10.1021/cr60274a001 ↗
51. A survey of Hammett substituent constants and resonance and field parameters10.1021/cr00002a004 ↗
52. Basic structural modifications for improving the practical properties of BODIPY10.1016/j.ccr.2022.214684 ↗
53. The potential of Pluronic polymeric micelles encapsulated with paclitaxel for the treatment of melanoma using subcutaneous and pulmonary metastatic mice models10.1016/j.biomaterials.2011.04.075 ↗
54. Preparation of pH sensitive Pluronic-docetaxel conjugate micelles to balance the stability and controlled release issues10.3390/ma8020379 ↗
55. Cancer cell membrane–encapsulated biomimetic nanoparticles for tumor immuno-photothermal therapy10.1016/j.cej.2023.142495 ↗
56. Design of Pluronic-based formulation for enhanced redaporfin-photodynamic therapy against pigmented melanoma10.1021/acsami.6b07031 ↗
57. Bi-directional protein transport between the ER and Golgi10.1146/annurev.cellbio.20.010403.105307 ↗
58. A practical guide to evaluating colocalization in biological microscopy10.1152/ajpcell.00462.2010 ↗
59. Image co-localization–co-occurrence versus correlation10.1242/jcs.211847 ↗